Poseida Therapeutics (PSTX) EBITDA (2020 - 2024)
Poseida Therapeutics (PSTX) EBITDA from Sep 30, 2020 to Sep 30, 2024. The TTM Poseida Therapeutics (PSTX) EBITDA is -$57M. You can adjust inflation or export chart.
Annual EBITDA
Quarterly EBITDA
Poseida Therapeutics (PSTX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -56.57% |
| 3 Years TTM | -28.33% |
| All Time TTM | -28.32% |
Annual EBITDA change of Poseida Therapeutics (PSTX)
| Year | EBITDA | Change |
|---|---|---|
| 2024 | -$33M | -73.73% |
| 2023 | -$124M | +126.20% |
| 2022 | -$55M | -59.98% |
| 2021 | -$137M | +10.41% |
| 2020 | -$124M | N/A |